... Methods: Whole-exomesequencing was performed to screen MECP2 and other ASD candidate genes for 120 patients diagnosed with ASD. The parents of patients who were identified with MECP2 mutation were ...
... process. Whole-exomesequencing (WES) allows simultaneous and rapid analysis of human genes, there- fore detection of all exome tractable mutations in genes known to be associated with ...
... DNA sequencing methods such as Sanger sequencing (11) for molecular characterization of affected patients, which involves many genes, is a time-consuming and expensive ...generation sequencing (NGS) ...
... Whole-exomesequencing (WES) studies designed to identify genes enriched for rare variants have been con- ducted for ALS. Association testing has typically been conducted at the gene level comparing ...
... performed whole-exomesequencing (WES) in nine discordant MZ twins to identify somatic mutational events in the affected twin that might exert a dominant negative ...Sanger sequencing of the ...
... Rapid developments in high throughput sequence cap- ture methods as well as in next generation sequencing (NGS) approaches have made wholeexomesequencing (WES) both technically feasible and ...
... in sequencing costs prompted the development of whole genome and RNA sequencing approaches for gene ...a wholeexomesequencing (WES) approach that allows rapid and cost- ...
... generation whole-exomesequencing (WES) opened a new page in Mendelian dis- ease gene discovery – enabling to study autosomal recessive diseases in a new ...
... generation sequencing (NGS) methods in re- cent years has changed the scope of human genomic ...perform whole genome sequencing (WGS) and wholeexomesequencing (WES) studies, ...
... next-generation sequencing in larger-scale genetic studies of simplex cases of CAS and possibly other motor speech ...clinical exomesequencing currently costs less than $5,000 per patient, the cost ...
... Background: Sarcoidosis (OMIM 181000) is a multi-systemic granulomatous disorder of unknown origin. Despite multiple genome-wide association (GWAS) studies, no major pathogenic pathways have been identified to date. To ...
... Accurate cancer risk and survival time prediction are important problems in personalized medicine, where disease diagnosis and prognosis are tuned to individuals based on their genetic material. Cancer risk prediction ...
... next-generation sequencing (NGS) technology and the decrease in costs for whole-exomesequencing (WES) and whole-genome sequening (WGS), has prompted its clinical application in several ...
... In this family, there was also a variant in the gene RREB1 remaining following filtering. This was a missense variant and, although in silico pathogenicity predictors did not support pathogenicity, there was a moderately ...
... routine whole-exomesequencing on patients is currently prohibitively expensive for most centers, precipitous cost decreases will make such sequencing feasible in the near future ...
... recently, whole-exomesequencing has been suc- cessful in elucidating causal genes for extremely rare subtypes of lipodystrophies, especially those due to de novo heterozygous variants ...and ...
... We extracted DNA from peripheral blood samples. Con fi rmation of mutations that met criteria for return was undertaken through Clinical Laboratory Improvement Amendment, 1988 (CLIA)-approved labo- ratories, either ...
... by wholeexome ...blood wholeexomesequencing demonstrated that several novel somatic mutations were identified in all three trios comply or against the trendy of tumor size ...
... Peritoneal metastasis occurs in more than half of patients with unresectable or recurrent gastric cancer and is associated with the worst prognosis. The associated genomic events and pathogenesis remain ambiguous. The ...